Bryan F. Cox - Jan 27, 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Signature
/s/ Sean Murphy, Attorney-in-Fact
Stock symbol
TLSI
Transactions as of
Jan 27, 2025
Transactions value $
$0
Form type
4
Date filed
1/29/2025, 06:09 PM
Previous filing
Dec 19, 2024
Next filing
Feb 19, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Award $0 +10.6K +12.3% $0.00 97K Jan 27, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Employee Stock Option (right to buy) Award $0 +63.8K $0.00 63.8K Jan 27, 2025 Common Stock 63.8K $5.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
F2 One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.